Toll Brothers
TOL · NYSE
About TOL
- Employees
- 4,900
- Headquarters
- Fort Washington, Pennsylvania
- Listed
- Jul 16, 1986
- Sector
- Consumer Discretionary
- Industry
- Household Durables
- Website
- tollbrothers.com
TOL key statistics
- Market cap
- 12.49B
- Price-earnings ratio
- 10.56
- Dividend yield
- 0.79%
- Average volume
- 1.09M
- Volume
- 1.05M
- Open price
- $132.99
- High today
- $135.68
- Low today
- $131.85
- 52 Week high
- $168.36
- 52 Week low
- $123.15
Toll Brothers (TOL) at a glance
Toll Brothers (TOL) last traded at $135.50, with a market cap of 12.49B, a price-to-earnings ratio of 10.56 and a dividend yield of 0.79%.
Today the stock has traded between $131.85 and $135.68. The current price is 2.8% above the day's low and 0.1% below its high.
Volume so far is 1.05M shares, in line with the average of 1.09M shares a day.
Over the past year Toll Brothers has ranged from $123.15 to $168.36, and now sits 27% of the way up that range.
Toll Brothers met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $2.97 per share against an estimate of $2.96.
The average analyst price target is $175.27, 29.3% above the current price, from 17 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy82.4%
- Hold11.8%
- Sell5.9%
- Low
- $123.22
- Now
- $135.50
- High
- $204.75
TOL earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 7.3% on average.
- Q3 FY24: reported $3.60 per share against an estimate of $3.35
- Q4 FY24: reported $4.63 per share against an estimate of $4.38
- Q1 FY25: reported $1.75 per share against an estimate of $2.06
- Q2 FY25: reported $3.50 per share against an estimate of $2.86
- Q3 FY25: reported $3.73 per share against an estimate of $3.64
- Q4 FY25: reported $4.58 per share against an estimate of $4.94
- Q1 FY26: reported $2.72 per share against an estimate of $2.59
- Q2 FY26: reported $2.97 per share against an estimate of $2.96
TOL news
- Piero Cingari
- Press releaseGlobe Newswire
Toll Brothers Announces Cash Dividend
- Press releaseGlobe Newswire
The Housing Market's Supply Problem Has an Assembly-Line Answer, and an Agreement Covering 1,500-Homes Will Put It to the Test
- Erica Kollmann
Toll Brothers Delivers 'Solid' Q3 Results in 'Challenging Market' CEO Says
- Press releaseGlobe Newswire
Toll Brothers Reports FY 2026 Third Quarter Results
- Kaustubh Bagalkote
Home Depot Could Swing $14.6 Billion After Earnings
- Press releaseGlobe Newswire
Toll Brothers Announces Cash Dividend
- Dylan Berman
Toll Brothers Shares Advance After Q2 Double Beat
Similar companies
Companies in the same industry as Toll Brothers
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.